Medical and Scientific Relations Division, Alzheimer's Association, Chicago, IL, USA.
Independent Science Writer, Philadelphia, PA, USA.
Alzheimers Dement. 2014 Jun;10(3 Suppl):S105-10. doi: 10.1016/j.jalz.2014.04.011.
By 2050, more than 13 million Americans of all ages are estimated to be living with Alzheimer's disease (AD), and the aggregate costs of care will swell to approximately $1.2 trillion. The rapidly climbing number of those affected with AD includes a growing population of aging military veterans affected who may have an added risk for the disease as a consequence of traumatic brain injury, posttraumatic stress disorder, and/or service-related injuries. The increasing number of individuals, the long duration of disability, and the rising cost of care for AD and other dementia to our society are important public health challenges facing many older adults. These challenges are further compounded by a burgeoning military veteran population that is much younger, with an increased risk of AD and other dementia, and who may experience decades-long periods of disability and care. This outlook underscores the critical need for investments in research at the federal and international levels to accelerate the pace of progress in developing breakthrough discoveries that will change the trajectory of AD and related dementia.
到 2050 年,预计将有超过 1300 万的美国各年龄段的人患有阿尔茨海默病(AD),护理费用总额将膨胀至约 1.2 万亿美元。受 AD 影响的人数迅速攀升,其中包括越来越多的老年退伍军人,他们可能因创伤性脑损伤、创伤后应激障碍和/或与服役相关的伤害而面临更高的患病风险。越来越多的人、残疾的持续时间长、以及 AD 和其他痴呆症的护理费用不断上涨,这些都是我们社会面临的重要公共卫生挑战,许多老年人都面临着这些挑战。退伍军人人数的不断增加,使情况变得更加复杂,他们年龄更小,患 AD 和其他痴呆症的风险增加,而且可能会经历长达数十年的残疾和护理。这种前景凸显了在联邦和国际层面进行研究投资的迫切需要,以加快突破性发现的进展速度,从而改变 AD 和相关痴呆症的发展轨迹。